Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03169543 · ClinicalTrials.gov registry record · NA

Neural Mechanisms Underlying the Antidepressant Effects of Sleep Deprivation

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT03169543: Completed NA study, sponsored by University of Pennsylvania.

NCT03169543 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03169543, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

From 40 to 60% of patients with depression experience a rapid and significant improvement of mood with one night of sleep deprivation (SD). The neural mechanisms underlying this effect have not been elucidated. Recent advances in functional neuroimaging have provided new opportunities to investigate state changes in regional brain function, along with a better understanding of the neural networks affected by depression and SD. Here we propose to study a group of N=48 antidepressant-free male and female patients with current depression symptom and N=12 healthy controls with no history of mood disorders before and after SD to provide mechanistic insight into the neural substrates underlying the antidepressant effects of SD. We hypothesize that SD-induced concurrent functional activity and connectivity changes in multiple brain networks related to different depressive symptom dimensions including emotion regulation, attention, arousal, self-referential, and reward processing will underlie the rapid and transient antidepressant effects of SD. Using an ABA design, multimodal brain imaging along with more traditional electroencephalographic (EEG) and neurobehavioral testing data will be acquired at baseline after normal sleep, during one night of total SD, and after one night of recovery sleep using a 5-day in laboratory protocol during which subjects will be continuously monitored by trained staff.

Interventions

  • BEHAVIORAL Sleep deprivation

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2016-04-01
Est. Completion 2020-02-28
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT03169543

The ClinicalTrials.gov registry entry for NCT03169543 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Sleep deprivation is the first listed.

NCT03169543 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03169543 about?

NCT03169543 is a clinical study titled "Neural Mechanisms Underlying the Antidepressant Effects of Sleep Deprivation". From 40 to 60% of patients with depression experience a rapid and significant improvement of mood with one night of sleep deprivation (SD). The neural mechanisms underlying this effect have not been elucidated. Recent advances in functional neuroimaging have provided new opportunities to investigate...

What is the current status of trial NCT03169543?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-04-01. Estimated completion is 2020-02-28.

What interventions are being tested in trial NCT03169543?

The interventions under investigation include: Sleep deprivation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03169543?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.